Workflow
饶毅发文疑批科伦药业董事长秀肌肉带货,直言麦角硫因是“假药”

Core Viewpoint - The article argues that the product Ergotine is a "fake drug" and criticizes the marketing tactics employed by Kelong Pharmaceutical and its chairman Liu Gexin, suggesting that the promotion of Ergotine is an example of unethical business practices [1][10]. Group 1: Criticism of Ergotine - Ergotine lacks sufficient evidence to be approved as a genuine drug, leading sellers to market it as a health supplement instead [7][4]. - The article emphasizes that if Ergotine had proven benefits for longevity, it would have been approved by regulatory authorities [7][1]. - The promotion of Ergotine is seen as a way to deceive consumers, with the author suggesting that purchasing such products is irresponsible [15][1]. Group 2: Marketing Tactics - Liu Gexin's personal promotion of Ergotine, including a video where he showcases his physique, is criticized as a marketing gimmick that distracts from the product's lack of scientific backing [2][1]. - The article highlights the absurdity of using a naked male figure to sell a product, labeling it as a "great invention" in the realm of marketing [11][1]. - The marketing strategy is portrayed as a reflection of a broader moral decline in the health supplement industry [15][1]. Group 3: Consumer Responsibility - Consumers are warned that purchasing Ergotine as a gift for parents is a form of deception, and true filial piety should involve spending quality time with them rather than buying questionable products [15][1]. - The article stresses that spending money on fake drugs does not equate to genuine care for loved ones [15][1].